| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/25/1992 | US5141922 Biologically active proteins and a method for their use |
| 08/25/1992 | US5141905 Bone morphogenic proteins induce bone and/or cartilage formation |
| 08/25/1992 | US5141867 Nucleotide sequence encoding a human immunodeficiency virus antigen |
| 08/25/1992 | US5141864 Monoclonal antibody recognizing alpha 2→3 bonds |
| 08/25/1992 | US5141856 Expression of purified ciliary neurotrophic factor |
| 08/25/1992 | US5141851 Isolated farnesyl protein transferase enzyme |
| 08/25/1992 | US5141849 Marker for early detection of human hydatidiform moles and choriocarcinomas |
| 08/25/1992 | US5141747 Denatured collagen membrane |
| 08/25/1992 | US5141745 Gene expression |
| 08/25/1992 | US5141742 Pure p97 protein antigen from genetically engineered cultured cell; immunogens |
| 08/25/1992 | CA1306709C Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3 |
| 08/25/1992 | CA1306708C Dicarboxylic acid transport genes |
| 08/25/1992 | CA1306707C Anti-human pulmonary adenocarcinoma specific monoclonal antibody |
| 08/25/1992 | CA1306706C Monoclonal antibodies to human gastrointestinal cancer |
| 08/25/1992 | CA1306691C Method of the virus-inactivating heat treatment of _-globulin and heat-treated aqueous solution containing the same |
| 08/25/1992 | CA1306690C Preparations active against pseudomonas aeruginosa infections and methods of producing them |
| 08/25/1992 | CA1306689C Method of preparing a vaccine against hepatitis b and the vaccine thus obtained |
| 08/25/1992 | CA1306670C Biological pesticide |
| 08/23/1992 | WO1992014821A2 Nestin expression as an indicator of neuroepithelial tumors |
| 08/23/1992 | WO1992014696A2 SUBSTITUTED α-AMINOALDEHYDES AND DERIVATIVES |
| 08/23/1992 | WO1992014482A1 Treatment of endotoxemia |
| 08/23/1992 | CA2104697A1 Nestin expression as an indicator of neuroepithelial tumors |
| 08/23/1992 | CA2104602A1 Substituted .alpha.-aminoaldehydes and derivatives |
| 08/23/1992 | CA2104217A1 Treatment of endotoxemia |
| 08/22/1992 | CA2061575A1 Plasmodium falciparum blood-stage antigen, the preparation and use thereof |
| 08/20/1992 | WO1992014818A2 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences |
| 08/20/1992 | WO1992014152A1 Rotavirus vp6 a diagnostic and targeting agent |
| 08/20/1992 | WO1992014150A1 Monoclonal antibodies against receptor-induced binding sites |
| 08/20/1992 | WO1992013972A1 Genetically engineered bacteria to identify and produce medically important agents |
| 08/20/1992 | WO1992013970A1 Immunoassay for detection of mutant p53 polypeptide in biological fluids |
| 08/20/1992 | WO1992013965A1 Method of immobilizing and crosslinking proteins and other molecules and uses thereof |
| 08/20/1992 | WO1992013964A1 Protein preparations |
| 08/20/1992 | WO1992013958A1 Receptor blocking peptides of fibroblast growth factor receptor |
| 08/20/1992 | WO1992013957A1 Stamen-specific promoters from corn |
| 08/20/1992 | WO1992013956A1 Stamen-specific promoters from rice |
| 08/20/1992 | WO1992013955A1 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| 08/20/1992 | WO1992013953A1 Microbial transformation of recalcitrant pcb compounds |
| 08/20/1992 | WO1992013952A1 Improved inhibitors of thrombin |
| 08/20/1992 | WO1992013951A1 Production of human serum albumin in methylotrophic yeast cells |
| 08/20/1992 | WO1992013950A2 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF β CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 08/20/1992 | WO1992013949A1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof |
| 08/20/1992 | WO1992013948A1 Cloning of a new member of the fibroblast growth factor (fgf) receptor family |
| 08/20/1992 | WO1992013947A1 CD4-GAMMA2 AND CD4-IgG2 CHIMERAS |
| 08/20/1992 | WO1992013941A1 Novel bacillus thuringiensis isolates |
| 08/20/1992 | WO1992013892A1 Monoclonal antibodies to putative hcv envelope region and methods for using same |
| 08/20/1992 | WO1992013891A1 Monoclonal antibody to human t cell receptors with gamma chains |
| 08/20/1992 | WO1992013890A1 Nematode vaccine |
| 08/20/1992 | WO1992013889A1 Nematode vaccine |
| 08/20/1992 | WO1992013888A1 Epithelial cell wound healing compositions and method |
| 08/20/1992 | WO1992013887A1 New cell adhesion peptides |
| 08/20/1992 | WO1992013885A1 MODIFIED INTERLEUKIN-1$g(b) |
| 08/20/1992 | WO1992013884A1 Liver-stage-specific peptide sequences of p. falciparum bearing epitopes capable of stimulating the t lymphocytes |
| 08/20/1992 | WO1992013883A1 Lhrh antagonists |
| 08/20/1992 | WO1992013882A1 Synthetic peptides suitable to enhance hiv-1 virus infectivity |
| 08/20/1992 | WO1992013879A1 Novel peptides with anticoagulatory effect |
| 08/20/1992 | WO1992013878A2 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
| 08/20/1992 | WO1992013875A1 Improved blood substitute |
| 08/20/1992 | WO1992013874A2 Angiogenic peptides |
| 08/20/1992 | WO1992013871A1 Polypeptides and polynucleotides useful for the diagnosis and treatment of pathogenic neisseria |
| 08/20/1992 | WO1992013870A1 Human platelet-derived growth factor receptors |
| 08/20/1992 | WO1992013867A1 Domains of extracellular region of human platelet derived growth factor receptor polypeptides |
| 08/20/1992 | WO1992013580A1 Enhanced suturing and means therefor |
| 08/20/1992 | WO1992013572A1 TECHNETIUM-99m LABELED POLYPEPTIDES FOR IMAGING |
| 08/20/1992 | WO1992013568A1 Vp6 encapsulated drug delivery |
| 08/20/1992 | WO1992013562A1 An immunotoxin with in vivo t cell suppressant activity |
| 08/20/1992 | WO1992013559A1 CD4-GAMMA1 AND CD4-IgG1 CHIMERAS |
| 08/20/1992 | WO1992013556A1 Combination of igf-i and igfbp for anabolism |
| 08/20/1992 | WO1992013554A1 Method of treating benign and malignant proliferative skin disease |
| 08/20/1992 | WO1992013553A2 Method and agents for promoting wound healing |
| 08/20/1992 | WO1992013550A1 Recombinant transferrins, transferrin half-molecules and mutants thereof |
| 08/20/1992 | WO1992013548A1 Method of inhibiting replication of hiv in macrophages |
| 08/20/1992 | WO1992013546A1 Mb-40 peptide that enhances the production of interleukin-1 and modulates age-associated immune response |
| 08/20/1992 | WO1992013526A1 Stabilisation of fibroblast growth factor using a polysaccharide |
| 08/20/1992 | WO1992013495A1 Fibrinogen based adhesive |
| 08/20/1992 | WO1992010514A3 Synthetic antigens for the detection of antibodies to hepatitis c virus |
| 08/20/1992 | WO1992007940A3 Bovine respiratory syncytial virus genes |
| 08/20/1992 | WO1992006113A3 Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant |
| 08/20/1992 | CA2638662A1 Specific peptidic sequences of p. falciparum heptatic stages that carry epitopes capable of stimulating t lymphocytes |
| 08/20/1992 | CA2103893A1 Monoclonal antibodies against receptor-induced binding sites |
| 08/20/1992 | CA2103676A1 Method and agents for promoting wound healing |
| 08/20/1992 | CA2103577A1 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
| 08/20/1992 | CA2103550A1 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences |
| 08/20/1992 | CA2101735A1 Vp6 encapsulated drug delivery |
| 08/20/1992 | CA2101632A1 Human platelet-derived growth factor receptors |
| 08/20/1992 | CA2079896A1 Method of treating benign and malignant proliferative skin disease |
| 08/20/1992 | CA2079871A1 Vaccine |
| 08/20/1992 | CA2079870A1 Vaccine |
| 08/20/1992 | CA2079461A1 Lhrh antagonists |
| 08/19/1992 | EP0499555A1 Recombinant DNA coding for a T-cell receptor chain, process for preparation and antibodies and pharmaceutical compositions comprising the same |
| 08/19/1992 | EP0499541A1 Process for the purification of a highly glycosylated protein |
| 08/19/1992 | EP0499266A1 Endothelin antagonist |
| 08/19/1992 | EP0499242A1 Stimulation of endosteal bone formation with a cell growth factor |
| 08/19/1992 | EP0499176A2 Monoclonal antibodies against human pancreatic islet cells |
| 08/19/1992 | EP0499162A2 GM-CSF inhibiting oligopeptides |
| 08/19/1992 | EP0499161A2 GM-CSF inhibiting antibodies |
| 08/19/1992 | EP0499080A2 Aminoacid derivatibes |
| 08/19/1992 | EP0499003A1 Polypeptides and peptides, particularly recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis |
| 08/19/1992 | EP0498905A1 Conformational epitopes of human immunodeficiency virus envelope glycoprotein gp120 |
| 08/19/1992 | EP0498856A1 Inhibitor of laminin neurite promoting activity |
| 08/19/1992 | EP0498827A1 Improved plasmid vectors for cellular slime moulds of the genus dictyostelium |